Market Entry into Europe for Pharma & Biotech - Charley Maxwell

In this episode, Charlie Maxwell of Orion GXP Consulting, breaks down what non‑EU pharma and biotech companies need to get right when launching in Europe, from choosing the right HQ location and operating model to deciding between building infrastructure and outsourcing to CDMOs, 3PLs and contract QPs. Charley explains why Europe is not one homogeneous market, how to avoid “tanking your pricing floor” through poor launch sequencing, and the crucial role of local quality, regulatory and distribution partners in making a European entry successful. Contact us at: [email protected] This episode is sponsored by Orion GXP Consulting.